Endoscopic Hemostasis Devices Market Size, Share, & Industry Analysis Report: By Product, By End Use (Hospitals and Outpatient Facilities), and By Region

Description

List of Tables

The endoscopic hemostasis devices market size is expected to reach USD 2,954.80 million by 2034, according to a new study by Polaris Market Research. The report "Endoscopic Hemostasis Devices Market Size, Share, & Industry Analysis Report: By Product, By End Use (Hospitals and Outpatient Facilities), and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Endoscopic hemostasis devices are defined as minimally invasive instruments designed to control active gastrointestinal bleeding during endoscopies procedures. The devices are witnessing increased relevance amid the growing demand for precision-based therapeutics. The transition toward device miniaturization and improved maneuverability allows for greater access to difficult-to-reach bleeding sites with improved clinical outcomes. These advancements are allowing endoscopists to perform more targeted interventions with reduced patient discomfort and faster recovery times. The integration of compact, user-friendly medical devices has become a strategic priority as healthcare providers seek to improve procedural efficiency, further reinforcing their adoption across clinical settings.

The integration of multifunctional technologies within single devices, combining clipping, coagulation, and injection capabilities into one system, further propels growth opportunities. This convergence of functionalities reduces procedural time and also minimizes the need for device exchange, improving workflow and safety during critical interventions. Additionally, the shift toward value-based care models is encouraging the adoption of versatile tools that can improve cost-efficiency while maintaining high standards of clinical effectiveness. Together, these trends are redefining the landscape of endoscopic bleeding management, aligning innovation with the evolving needs of the modern gastroenterological practice.

Endoscopic Hemostasis Devices Market Report Highlights

In terms of product, the ligation clips segment led the market in 2024, favored for their clinical efficacy, ease of use, and broad adoption in gastrointestinal bleeding management.

Based on end use, the outpatient segment is anticipated to grow the fastest, driven by the shift toward minimally invasive techniques and cost-efficient healthcare solutions.

In 2024, North America held the largest revenue share, supported by advanced healthcare systems, high adoption of minimally invasive procedures, and leading device manufacturers.

The Asia Pacific endoscopic hemostasis devices market is expected to grow the fastest, propelled by increasing GI disorder prevalence, greater awareness of endoscopic treatments, and improving healthcare infrastructure.

A few global key market players include Ambu A/S; Boston Scientific Corporation; CONMED Corporation; Cook Medical Inc.; FUJIFILM India Private Limited; HOYA Corporation (PENTAX Medical); Johnson & Johnson; KARL STORZ; Medtronic; MICRO-TECH (Nanjing) Co., Ltd.; Olympus America Inc.; Richard Wolf GmbH; Smith+Nephew; STERIS; and Stryker.

Polaris Market Research has segmented the endoscopic hemostasis devices market report on the basis of product, end use, and region:

By Product Outlook (Revenue, USD Million, 2020-2034)

Ligation Clips

Ligation Bands

Hemorrhoidal

Esophageal

Injection Needles

Hemostatic Spray

Thermal Probes

Contact Probes

Noncontact Probes

Argon Plasma Coagulation (APC)

Radiofrequency Ablation (RFA)

By End Use Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Outpatient Facilities

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Product Code: PM5753

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Endoscopic Hemostasis Devices Market Insights

4.1. Endoscopic Hemostasis Devices Market - Market Snapshot
4.2. Endoscopic Hemostasis Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Gastrointestinal Disorders
  - 4.2.1.2. Increasing Advancements and Product Innovation
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Devices
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Endoscopic Hemostasis Devices Market Trends
4.6. Value Chain Analysis

5. Global Endoscopic Hemostasis Devices Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
5.3. Ligation Clips
- 5.3.1. Global Endoscopic Hemostasis Devices Market, by Ligation Clips, by Region, 2020-2034 (USD Million)
5.4. Ligation Bands
- 5.4.1. Global Endoscopic Hemostasis Devices Market, by Ligation Bands, by Region, 2020-2034 (USD Million)
- 5.4.2. Hemorrhoidal
  - 5.4.2.1. Global Endoscopic Hemostasis Devices Market, by Hemorrhoidal, by Region, 2020-2034 (USD Million)
- 5.4.3. Esophageal
  - 5.4.3.1. Global Endoscopic Hemostasis Devices Market, by Esophageal, by Region, 2020-2034 (USD Million)
5.5. Injection Needles
- 5.5.1. Global Endoscopic Hemostasis Devices Market, by Injection Needles, by Region, 2020-2034 (USD Million)
5.6. Hemostatic Spray
- 5.6.1. Global Endoscopic Hemostasis Devices Market, by Hemostatic Spray, by Region, 2020-2034 (USD Million)
5.7. Thermal Probes
- 5.7.1. Global Endoscopic Hemostasis Devices Market, by Thermal Probes, by Region, 2020-2034 (USD Million)
- 5.7.2. Contact Probes
  - 5.7.2.1. Global Endoscopic Hemostasis Devices Market, by Contact Probes, by Region, 2020-2034 (USD Million)
- 5.7.3. Noncontact Probes
  - 5.7.3.1. Global Endoscopic Hemostasis Devices Market, by Noncontact Probes, by Region, 2020-2034 (USD Million)
5.8. Argon Plasma Coagulation (APC)
- 5.8.1. Global Endoscopic Hemostasis Devices Market, by Argon Plasma Coagulation (APC), by Region, 2020-2034 (USD Million)
5.9. Radiofrequency Ablation (RFA)
- 5.9.1. Global Endoscopic Hemostasis Devices Market, by Radiofrequency Ablation (RFA), by Region, 2020-2034 (USD Million)

6. Global Endoscopic Hemostasis Devices Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
6.3. Hospitals
- 6.3.1. Global Endoscopic Hemostasis Devices Market, by Hospitals, by Region, 2020-2034 (USD Million)
6.4. Outpatient Facilities
- 6.4.1. Global Endoscopic Hemostasis Devices Market, by Outpatient Facilities, by Region, 2020-2034 (USD Million)

7. Global Endoscopic Hemostasis Devices Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Endoscopic Hemostasis Devices Market Assessment, By Geography, 2020-2034 (USD Million)
7.3. Endoscopic Hemostasis Devices Market - North America
- 7.3.1. North America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.3.2. North America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.3.3. Endoscopic Hemostasis Devices Market - US
  - 7.3.3.1. US: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.3.3.2. US: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.3.4. Endoscopic Hemostasis Devices Market - Canada
  - 7.3.4.1. Canada: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.3.4.2. Canada: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
7.4. Endoscopic Hemostasis Devices Market - Europe
- 7.4.1. Europe: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.2. Europe: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.3. Endoscopic Hemostasis Devices Market - UK
  - 7.4.3.1. UK: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.4.3.2. UK: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.4. Endoscopic Hemostasis Devices Market - France
  - 7.4.4.1. France: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.4.4.2. France: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.5. Endoscopic Hemostasis Devices Market - Germany
  - 7.4.5.1. Germany: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.4.5.2. Germany: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.6. Endoscopic Hemostasis Devices Market - Italy
  - 7.4.6.1. Italy: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.4.6.2. Italy: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.7. Endoscopic Hemostasis Devices Market - Spain
  - 7.4.7.1. Spain: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.4.7.2. Spain: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.8. Endoscopic Hemostasis Devices Market - Netherlands
  - 7.4.8.1. Netherlands: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.4.8.2. Netherlands: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.9. Endoscopic Hemostasis Devices Market - Russia
  - 7.4.9.1. Russia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.4.9.2. Russia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.10. Endoscopic Hemostasis Devices Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.4.10.2. Rest of Europe: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
7.5. Endoscopic Hemostasis Devices Market - Asia Pacific
- 7.5.1. Asia Pacific: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.2. Asia Pacific: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.3. Endoscopic Hemostasis Devices Market - China
  - 7.5.3.1. China: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.5.3.2. China: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.4. Endoscopic Hemostasis Devices Market - India
  - 7.5.4.1. India: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.5.4.2. India: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.5. Endoscopic Hemostasis Devices Market - Malaysia
  - 7.5.5.1. Malaysia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.5.5.2. Malaysia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.6. Endoscopic Hemostasis Devices Market - Japan
  - 7.5.6.1. Japan: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.5.6.2. Japan: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.7. Endoscopic Hemostasis Devices Market - Indonesia
  - 7.5.7.1. Indonesia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.5.7.2. Indonesia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.8. Endoscopic Hemostasis Devices Market - South Korea
  - 7.5.8.1. South Korea: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.5.8.2. South Korea: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.9. Endoscopic Hemostasis Devices Market - Australia
  - 7.5.9.1. Australia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.5.9.2. Australia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.10. Endoscopic Hemostasis Devices Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.5.10.2. Rest of Asia Pacific: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
7.6. Endoscopic Hemostasis Devices Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.2. Middle East & Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6.3. Endoscopic Hemostasis Devices Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.6.3.2. Saudi Arabia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6.4. Endoscopic Hemostasis Devices Market - UAE
  - 7.6.4.1. UAE: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.6.4.2. UAE: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6.5. Endoscopic Hemostasis Devices Market - Israel
  - 7.6.5.1. Israel: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.6.5.2. Israel: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6.6. Endoscopic Hemostasis Devices Market - South Africa
  - 7.6.6.1. South Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.6.6.2. South Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6.7. Endoscopic Hemostasis Devices Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.6.7.2. Rest of Middle East & Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
7.7. Endoscopic Hemostasis Devices Market - Latin America
- 7.7.1. Latin America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.2. Latin America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.7.3. Endoscopic Hemostasis Devices Market - Mexico
  - 7.7.3.1. Mexico: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.7.3.2. Mexico: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.7.4. Endoscopic Hemostasis Devices Market - Brazil
  - 7.7.4.1. Brazil: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.7.4.2. Brazil: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.7.5. Endoscopic Hemostasis Devices Market - Argentina
  - 7.7.5.1. Argentina: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.7.5.2. Argentina: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.7.6. Endoscopic Hemostasis Devices Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  - 7.7.6.2. Rest of Latin America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Ambu A/S
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Boston Scientific Corporation
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. CONMED Corporation.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Cook Medical Inc.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. FUJIFILM India Private Limited
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. HOYA Corporation. (PENTAX Medical)
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Johnson & Johnson
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. KARL STORZ
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Medtronic
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. MICRO-TECH (Nanjing) Co., Ltd.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Olympus America Inc.
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
9.12. Richard Wolf GmbH.
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
9.13. Smith+Nephew
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
9.14. STERIS
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
9.15. Stryker
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development